title: Adjustment of antiretroviral regimen may lead to HBV reactivation even in patients with past HBV infection serological profile.
abstract: We report a reactivation of hepatitis B virus (HBV) in an human immunodeficiency virus (HIV) patient despite a serological profile of past HBV infection with anti-HBs and anti-HBc antibodies, following the interruption of tenofovir/emtricitabine. In HBV-HIV co-infected patients, close monitoring of HBV viral load and serological markers is required for antiretroviral management, particularly after interruption of drugs active for HBV.
authors: INSERM UMR-S 943 and University Pierre and Marie Curie (UPMC) Paris VI, Paris, France, sophie.seang@yahoo.fr.
authors: Sophie
authors: S
authors: Seang
authors: Vincent
authors: V
authors: Thibault
authors: Marc Antoine
authors: MA
authors: Valantin
authors: Christine
authors: C
authors: Katlama
mesh_terms: D044966:Anti-Retroviral Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000914:Antibodies, Viral / Q000097:blood; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology*; D015497:HIV-1 / Q000302:isolation & purification*; D006509:Hepatitis B / Q000097:blood / Q000276:immunology / Q000821:virology*; D006515:Hepatitis B virus / Q000502:physiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D019562:Viral Load; D014775:Virus Activation / Q000187:drug effects
chemical_list: D044966:Anti-Retroviral Agents; D000914:Antibodies, Viral